Skip to main content
Equibles

BROOKS · Brooks Laboratories Limited · Financials

Use BROOKS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BROOKS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
64.23 INR -1.76 (-2.67%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 3263 Avg daily vol (3M) 12.39K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
857.38M +3.9%
FY2026 Revenue FY2021–FY2026
Net Income
245.53M +346.3%
FY2026 Net Income FY2021–FY2026
Operating Cash Flow
92.93M +268.7%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021
INR 789.85M 857.38M 825.57M 794.86M 632.05M 910.77M 772.47M
INR 16.69M 15.9M 16.02M 17.73M 70.27M 73.51M 71.43M
INR 7.08M 8.35M 10.28M 8.45M 21.83M 30.97M 30.98M
INR — — — — — -238.98M —
INR 53.17M 0 1.75M 259K -73.24M -45.85M 103.82M
INR 728.14M 245.53M -99.67M -195.92M -209M -161.88M -193.76M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.